-
Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic
medicine for the
treatment of
neovascular (wet) age-related
macular degeneration...
- of the body.
Drugs such as aflibercept, bevacizumab, ranibizumab, and
pegaptanib can
inhibit VEGF and
control or slow
those diseases. In 1970,
Judah Folkman...
-
below the
retinal pigment epithelium.
Angiogenesis inhibitors include pegaptanib,
ranibizumab and
bevacizumab (known by a
variety of
trade names, such...
-
Cochrane Systematic Review studied the
effectiveness of
ranibizumab and
pegaptanib, on
patients who have
macular edema caused by
central retinal vein occlusion...
-
Commercial products and
companies based on
aptamers include the drug
Macugen (
pegaptanib) and the
clinical diagnostic company SomaLogic. The
International Society...
-
studied the
effectiveness of two anti-VEGF treatments,
ranibizumab and
pegaptanib, on
patients with
macular edema caused by CRVO. Parti****nts on both treatment...
- injection) –
Pharmacologic stress agent for
myocardial perfusion scan
Macugen (
pegaptanib sodium) – Anti-angiogenic –
marketed with
Gilead Sciences in the US and...
-
Cediranib Fruquintinib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib Rebastinib Regorafenib Semaxanib Sorafenib Sunitinib Toceranib Tivozanib...
-
evidence supports the use of anti-VEGF antibodies, such as
bevacizumab or
pegaptanib which seems to
improve outcomes when used in
conjunction with
laser therapy...
-
Chemokine Ligand 12 (CXCL2). An
example of an RNA
aptamer therapy includes Pegaptanib (aka
Macugen ® ), the only FDA-approved RNA
aptamer treatment. Originally...
